DELEX Healthcare Group Inc. Profitable, Fast-Growing Pharma Company Revolutionizing Critical Care Meeting the Gaps in Critical Care with Innovative Pharmaceutical Solutions

Delex Healthcare Group Inc. (DELEX), a rapidly expanding pharmaceutical and healthcare company, continues to make significant strides in addressing critical care challenges. Founded in 2017 and incorporated in Delaware, USA, DELEX specializes in the development, distribution, and marketing of pharmaceutical products through its subsidiaries, including DELEX Pharma International Inc. (DELEX Pharma), DLX Holdings Corp., and JMN Brother’s Pharma Limited Inc.